EXACT Therapeutics minutes from Annual General Meeting June 28, 2024

28 Jun 2024 11:47 CEST

OSLO, 28 June 2024: EXACT Therapeutics AS (“EXACT-Tx”, “the Company” Euronext
Growth: EXTX) held its Annual General Meeting on June 28th 2024 at 10:30 CEST.

All proposed resolutions were approved.

Please find enclosed the minutes of the meeting including appendices. The
minutes will also be available on the company website: www.exact-tx.com


ENDS
For more information, please contact:

Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com

John M. Edminson CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com


About EXACT-Tx
EXACT-Tx is a clinical-stage Norwegian precision health company developing a
technology platform for targeted therapeutic enhancement – Acoustic Cluster
Therapy (ACT®). ACT® follows a unique approach to ultrasound-mediated, targeted
drug enhancement – with the potential to enable or significantly amplify the
clinical utility of a wide range of therapeutic agents across a multitude of
indications including within oncology (chemotherapy, immunotherapy) and brain
diseases. www.exact-tx.com

More information:
Access the news on Oslo Bors NewsWeb site

622660_20240628 AGM Minutes EXACT Therapeutics AS - SIGN.pdf